Startups
PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health.
The company’s first product Engility CTMS simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility CTMS utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
The company’s first product Engility CTMS simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility CTMS utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
Overview
Location
United Kingdom, England, Nottingham
Employees
11-50
Phone
+44 115 748 6712
Total raised
$2.02M
Founded date
2016
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 23, 2018 | Funding round | $700.61K |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 3, 2019 | Pharmaseal International Closes £1M Funding Round | Pharmaseal International, a Nottingham, UK-based company which has developed a platform to allow pharmaceutical firms to manage clinical trials more effectively, raised almost £1m in funding. Backers included the MEIF Proof of Concept &... |
| Jan 25, 2018 | Clinical trials software secures £500k investment from Mercia | A Nottingham business which is developing new software to help pharmaceutical companies to manage clinical trials more effectively has secured a £500,000 equity investment from Mercia Fund Managers and angel investors. |
| Jan 23, 2018 | Pharmaseal International Secures £500k in Equity Funding | Pharmaseal International, a Nottingham, UK-based clinical trials software company, secured £500k in equity funding. Backers included Mercia Fund Managers and angel investors. In conjunction withe the funding, Dr Neil Rotherham, the founder ... |
Reviews 0
FAQ about PHARMASEAL
When was PHARMASEAL founded?
PHARMASEAL was founded in 2016.
How much funding has PHARMASEAL raised?
PHARMASEAL has raised $2.02M in total across 2 funding rounds.
What funding rounds has PHARMASEAL raised?
Parsers VC lists 2 funding rounds of PHARMASEAL, among them a funding round of $700.61K on Jan 23, 2018.
What has the press written about PHARMASEAL?
Parsers VC has collected 4 articles mentioning PHARMASEAL, among them “Pharmaseal International Closes £1M Funding Round” (May 3, 2019) and “Clinical trials software secures £500k investment from Mercia” (Jan 25, 2018).
Is PHARMASEAL still active?
Yes, PHARMASEAL is active; its latest activity on Parsers VC dates from May 7, 2019.